Meridia Recall Coming Soon?

(CBS) This month, the FDA will decide the fate of the controversial diet pill Meridia.
On Wed., Sept. 1, the New England Journal of Medicine weighed in with an editorial calling for it to be pulled from the market after a new study revealed an increased risk for heart attacks in some [...]

Report: Accutane Causes Crohn’s, Colitis and IBD

Common Acne Drugs Can Trigger Bowel Problems
NEW YORK —  Acne is a difficult enough burden for a young person to bear. Now there’s evidence that antibiotics commonly prescribed to help control severe breakouts may, in a very small number of patients, lead to inflammatory bowel disease.
Bowel disorders linked to acne treatment are “a [...]

Accutane Ends Career of Young Actor – Martin Sheen to Testify At Trial

Tuesday August 3, 2010
Actor John Marshall has filed suit against Roche AG, the maker of Accutane. The 43-year-old Marshall, who played U.S. Marine Louden Downey in the 1992 hit movie “A Few Good Men,” claims he developed inflammatory bowel disease, or IBD, from taking Accutane. The disease, Marshall alleges, ruined his acting career.
Marshall’s Accutane [...]

REGLAN IS LEADING CAUSE OF TARDIVE DYSKINESIA

Here is an article from the Huffington Post:
Last year, the Food & Drug Administration issued a black box warning, the strongest of its kind, for the drug Reglan and its generic forms metoclopramide, stating that the medication had “been linked to tardive dyskinesia.” In fact, Reglan and metoclopramide use has been identified as the leading [...]

Lawsuit: Super Poligrip User Became Permanently Injured

Super Poligrip Recall

The manufacturer of Super PoliGrip announced last week that it is removing zinc from its denture cream formula, the latest and most dramatic response to criticism from consumer groups and an ever-growing list of lawsuits claiming health problems as a result of excessive zinc intake.
A press release by GlaxoSmithKline announced that the company is pulling [...]

REPORT: PAXIL MANUFACTURER PAID $200 MILLION TO RESOLVE BIRTH DEFECT SUITS SO FAR!

GlaxoSmithKline Plc has paid almost $1 billion to resolve lawsuits over Paxil since it introduced the antidepressant in 1993, including $200 million to settle Paxil addiction and birth-defect cases.